Back
ESC Premium Access

First-in-man study of the dedicated bifurcation cobalt-chromium sirolimus-eluting stent: 9-month interim results.

Session: Poster Session 6 - Coronary interventions
Topic: Stents
Speaker: Professor R. Gil (Warsaw, PL)
Event: ESC Congress 2018

Congress Presentation

Add to my library

Like

About the speaker

Professor Robert Gil

National Medical Institute of the Ministry of Internal Affairs, Warsaw (Poland)
1 presentation
0 follower

9 more presentations in this session

A meta-analysis of randomised controlled trials to compare safety and efficacy of everolimus/sirolimus bioabsorbable polymer with second-generation durable-polymer drug eluting stents

Speaker: Associate Professor K. Singh (Gold Coast, AU)

Access
Abstract
Slides
Like
Thumbnail

Unique stent design with continuous cobalt wire can avoid protruding immediately after percutaneous coronary intervention compared to classical tubed stent.

Speaker: Doctor D. Nakamura (Osaka, JP)

Access
Abstract
Like
Thumbnail

Clinical impact of implanted stent length on clinical outcomes in patients treated with second-generation DES: a pooled analysis from RESET and NEXT trial

Speaker: Mr H. Watanabe (Wakayama, JP)

Access
Abstract
Like
Thumbnail

A five-year follow-up of randomised studies comparing outcomes between bioabsorbable-polymer and durable-polymer drug-eluting stents: systematic review and meta-analysis

Speaker: Associate Professor K. Singh (Gold Coast, AU)

Access
Abstract
Slides
Like
Thumbnail

Drug-eluting balloon in the side branch of bifurcation lesions induces late lumen enlargement in the follow-up period

Speaker: Doctor D. Gulin (Jonkoping, SE)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Poster Session 6 - Coronary interventions

Speakers: Professor R. Gil, Associate Professor K. Singh, Doctor D. Nakamura, Mr H. Watanabe, Associate Professor K. Singh...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources